<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://zh.app/en/r/vrt-2026-08-06</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>Vertiv Holdings Co: Deferred Revenue Doubled to 3.63 Billion USD After a 110 Million USD Second-Quarter Revenue Miss, While Full-Year Guidance Implies 4.33 Billion USD of Fourth-Quarter Sales</news:title></news:news></url>
  <url><loc>https://zh.app/cn/r/vrt-2026-08-06</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>Vertiv：递延收入翻倍至 36.3 亿美元，二季度收入短了 1.1 亿美元，全年指引隐含四季度 43.3 亿美元销售额</news:title></news:news></url>
  <url><loc>https://zh.app/en/r/samsung-2026-08-06</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>Samsung Electronics: Device Solutions Supplied 99.7% of Second-Quarter Operating Profit, and at 230,500 Won the Shares Already Trade Above the 185,000 Won Conservative Value</news:title></news:news></url>
  <url><loc>https://zh.app/cn/r/samsung-2026-08-06</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>Samsung Electronics：Device Solutions 贡献第 2 季度营业利润的 99.7%，230,500 韩元股价已高于 185,000 韩元保守价值</news:title></news:news></url>
  <url><loc>https://zh.app/en/r/dhr-2026-08-06</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>Danaher: Orders and Peers Make the Bioprocessing Recovery Underwritable, but 3-4% Core Growth at 23 Times Earnings Leaves No Margin of Safety</news:title></news:news></url>
  <url><loc>https://zh.app/cn/r/dhr-2026-08-06</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>丹纳赫：订单与同业数据让生物工艺复苏可以承保，但 3-4% 的核心增长配 23 倍市盈率没有安全边际</news:title></news:news></url>
  <url><loc>https://zh.app/en/r/csl-2026-08-06</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>Carlisle Companies: Second-Quarter Sales Rose 8.3% While Adjusted EBITDA Margin Fell 70 Basis Points, and Full-Year Guidance Went Up on Revenue and Down on Margin</news:title></news:news></url>
  <url><loc>https://zh.app/cn/r/csl-2026-08-06</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>Carlisle Companies：二季度销售额增长 8.3%，调整后 EBITDA 利润率下滑 70 个基点，全年指引收入上调、利润率下调</news:title></news:news></url>
  <url><loc>https://zh.app/en/r/cr-2026-08-06</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>Crane Company: Aerospace Compounds on Its Own, but Four-Fifths of the Headline Growth Was Bought and 32 Times Earnings Leaves No Cushion</news:title></news:news></url>
  <url><loc>https://zh.app/cn/r/cr-2026-08-06</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>克瑞公司：航空航天板块自身在复利，但报表增速的五分之四是买来的，32 倍市盈率没有留下缓冲</news:title></news:news></url>
  <url><loc>https://zh.app/en/r/1sxp-2026-08-06</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>SCHOTT Pharma: A GLP-1 Boom Priced by the Dose, Not the Drug, and a Capacity Bill That Has Yet to Prove Its Return</news:title></news:news></url>
  <url><loc>https://zh.app/cn/r/1sxp-2026-08-06</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>肖特医药：一场按剂量计价而非按药价分成的 GLP-1 热潮，以及一笔尚未证明回报的产能账单</news:title></news:news></url>
  <url><loc>https://zh.app/en/r/nio-2026-08-05</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-05</news:publication_date><news:title>NIO Inc.: Vehicle Margin Reached 18.8% and Adjusted Operating Profit Turned Positive in the First Quarter of 2026 While GAAP Operating Income Stayed Negative</news:title></news:news></url>
  <url><loc>https://zh.app/cn/r/nio-2026-08-05</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-05</news:publication_date><news:title>蔚来汽车：2026 年第 1 季度整车毛利率达 18.8%，调整后经营利润转正，但 GAAP 经营利润仍为负</news:title></news:news></url>
  <url><loc>https://zh.app/en/r/mrk-2026-08-05</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-05</news:publication_date><news:title>Merck &amp; Co.: KEYTRUDA and QLEX Generated 50.4% of Second-Quarter Revenue While Subcutaneous Sales Rose to 463 Million Dollars Before the 2028 Patent Cliff</news:title></news:news></url>
  <url><loc>https://zh.app/cn/r/mrk-2026-08-05</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-05</news:publication_date><news:title>Merck：KEYTRUDA 与 QLEX 贡献第 2 季度收入的 50.4%，皮下注射剂型销售额升至 4.63 亿美元，2028 年专利悬崖在即</news:title></news:news></url>
  <url><loc>https://zh.app/en/r/loreal-2026-08-05</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-05</news:publication_date><news:title>L’Oréal: Record First-Half Margins and a Broad-Based Recovery, but 30 Times Earnings Already Prices In the China and Gucci Upside</news:title></news:news></url>
  <url><loc>https://zh.app/cn/r/loreal-2026-08-05</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-05</news:publication_date><news:title>欧莱雅：上半年利润率创纪录、复苏面全线转正，但 30 倍市盈率已把中国与古驰的上行提前定价</news:title></news:news></url>
  <url><loc>https://zh.app/en/r/etn-2026-08-05</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-05</news:publication_date><news:title>Eaton: Record Orders and a Cleaner Post-Mobility Portfolio, but 42 Times Free Cash Flow Leaves No Conservative-Case Margin of Safety</news:title></news:news></url>
  <url><loc>https://zh.app/cn/r/etn-2026-08-05</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-05</news:publication_date><news:title>伊顿：订单创纪录，剥离车辆业务后组合更清晰，但 42 倍自由现金流缺乏保守情景安全边际</news:title></news:news></url>
  <url><loc>https://zh.app/en/research/cheap-for-a-reason-2026-08-06</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>Cheap With a Grievance, or Cheap for a Reason? A Value-Trap Test From 1,013 Scorecards</news:title></news:news></url>
  <url><loc>https://zh.app/cn/research/cheap-for-a-reason-2026-08-06</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>便宜有冤，还是便宜有道理？1,013 张记分卡练出的价值陷阱判别法</news:title></news:news></url>
  <url><loc>https://zh.app/en/research/buffett-screen-2026-08</loc><news:news><news:publication><news:name>Zen Horizon</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>The Buffett Quality Screen, First Edition: 1,790 Companies, Six Lenses, and the 16 That Survive Both of Our Boards</news:title></news:news></url>
  <url><loc>https://zh.app/cn/research/buffett-screen-2026-08</loc><news:news><news:publication><news:name>纵横研报</news:name><news:language>zh-cn</news:language></news:publication><news:publication_date>2026-08-06</news:publication_date><news:title>巴菲特「好公司」榜首期：1,790 家公司、六道镜头，以及同时活过两张榜的 16 家</news:title></news:news></url>
</urlset>